check_circleStudy Completed
Cystic Fibrosis
Bayer Identifier:
Trial_0696
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Pilot study to compare acarbose (BAY g 5421) with placebo in respect of efficacy and tolerability in patients with cystic fibrosis and pathological glucose tolerance
Trial purpose
Please see attached Study Results Summary below.
Key Participants Requirements
Sex
BothAge
7 - 25 YearsTrial summary
Enrollment Goal
12Trial Dates
November 1993 - September 1995Phase
Phase 3Could I Receive a placebo
N/AProducts
Acarbose (Precose/Glucobay, BAYG5421)Accepts Healthy Volunteer
N/ATrial design
Trial Type
InterventionalIntervention Type
N/ATrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A